Katy,
I know I have offered encouragement over the years and there have been set backs. However I have never felt more positive about this company than I do now, especially after the recent AGM and discussions with directors. On both drugs, we have excellent academic research giving very high support to our theories and the mode of action of both drugs. We have never had this before. The work of Richard Bond, financed by the NIH, confirms that Nadilol is a unique drug to treat all respiratory diseases. It is the only drug that will heal the lung. The market is huge. Cpn10 is supported by the work in London published in a reputable journal. We will have interim results in both drugs by the end of year and according to Mitchell Glass have a large number of the biggest Companies anxious to discuss a deal. I have never seen Mitchell so up beat.
IVX Price at posting:
5.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)